Working… Menu

Long-Term Follow-Up Gene Therapy Study for Achromatopsia CNGB3 and CNGA3

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03278873
Recruitment Status : Recruiting
First Posted : September 12, 2017
Last Update Posted : March 24, 2021
Syne Qua Non Limited
EMAS Pharma
Information provided by (Responsible Party):
MeiraGTx UK II Ltd

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 10, 2024
Estimated Study Completion Date : August 7, 2024